Coronary interventions

STEMI

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well.

Filters

Search by author

Filter by type

Showing 1-20 of 156 articles

Coronary interventions

Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition

Gragnano F, Spirito A, Corpataux N, Vaisnora L, Galea R, Gargiulo G, Siontis G, Praz F, Lanz J, Billinger M, Hunziker L, Stortecky S, Pilgrim T, Bär S, Ueki Y, Capodanno D, Urban P, Pocock S, Mehran R, Heg D, Windecker S, Räber L, Valgimigli M

June 8, 2021 | 10.4244/EIJ-D-21-00181

Coronary interventions

Near-Infrared Spectroscopy to Predict Microvascular Obstruction after Primary Percutaneous Coronary Intervention

Terada K, Kubo T, Madder R, Ino Y, Takahata M, Shimamura K, Shiono Y, Nishi T, Emori H, Higashioka D, Khalifa AKM, Wada T, Akasaka T

June 8, 2021 | 10.4244/EIJ-D-20-01421

Coronary interventions

Clopidogrel Monotherapy in Patients with and without On-Treatment High Platelet Reactivity: a SMART-CHOICE sub-study

Lee SH, Lee SY, Chun WJ, Song YB, Choi S, Jeong J-O, Oh SK, Yun K, Koh Y, Bae J-W, Choi JW, Gwon H, Hahn J

May 25, 2021 | 10.4244/EIJ-D-21-00223

Coronary interventions

A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial

Noc M, Laanmets P, Neskovic A, Petrović M, Stanetic B, Aradi D, Kiss RG, Ungi I, Merkely B, Hudec M, Blasko P, Horvath I, Davies J, Vukcevic V, Holzer M, Metzler B, Witkowski A, Erglis A, Fister M, Nagy G, Bulum J, Édes I, Średniawa B, Erlinge D, Keeble T, Keeble T

May 18, 2021 | 10.4244/EIJ-D-21-00348

Coronary interventions

Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis

Piccolo R, Oliva A, Avvedimento M, Franzone A, Windecker S, Vaglimigli M, Esposito G, Jüni P

April 13, 2021 | 10.4244/EIJ-D-20-01197

Coronary interventions

Clinical Outcomes By Angiographic Type Of Spontaneous Coronary Artery Dissection

Mori R, Macaya F, Giacobbe F, Salinas P, Pavani M, Boi A, Bettari L, Rolfo C, Porto I, Gonzalo N, Varbella F, Cerrato E, Escaned J

March 2, 2021 | 10.4244/EIJ-D-20-01275

Coronary interventions

Plaque characteristics in patients with ST-segment elevation myocardial infarction and early spontaneous reperfusion

Guo J, Chen J, Wang G, Liu Z, Niu D, Wu Y, Song J, Gao J, Fan Z, Zhang Y, Si J, Zuo X, Shi N, Miao Z, Bai Z, Zhang L, Liu B, Li J

January 26, 2021 | 10.4244/EIJ-D-20-00812

Coronary interventions

Efficacy of Thin- Versus Thick-Strut Polymer-Free Biolimus-Eluting Stents: the Biofreedom QCA Randomized Trial

Sabaté M, Okkels-Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Pérez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Lassen J

January 13, 2021 | 10.4244/EIJ-D-20-01162

Coronary interventions

National French Registry of Spontaneous Coronary Artery Dissections: Prevalence of Fibromuscular Dysplasia and Genetic Analyses

Combaret N, Gerbaud E, Derimay F, Souteyrand G, Cassagnes L, Bouajila S, Berrandou T, Rangé G, Meneveau N, Harbaoui B, Lattuca B, Bouatia-Naji N, Motreff P, Lambert C, Spaulding C, Benamer H, Jeunemaitre X, Georges A, Bresson D, Mangin L

December 15, 2020 | 10.4244/EIJ-D-20-01046

Coronary interventions

Clinical Usefulness of a Novel Optical Coherence Tomography Procedure, “Low Molecular Weight Dextran Infusion Followed by Catheter PUSH (D-PUSH)”

Kobayashi N, Shibata Y, Okazaki H, Shirakabe A, Takano M, Miyauchi Y, Asai K, Shimizu W

November 24, 2020 | 10.4244/EIJ-D-20-00996

Coronary interventions

Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography

Satogami K, Ozaki Y, Ota S, Katayama Y, Ino Y, Akasaka T

November 17, 2020 | 10.4244/EIJ-D-20-00985

Coronary interventions

A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial

Jang WJ, Lee JB, Song YB, Choi K, Choi S, Chun WJ, Oh JH, Park IH, Doh J, Jeong J-O, Park J-S, Gwon H, Hahn J

November 10, 2020 | 10.4244/EIJ-D-20-00556

Coronary interventions

Predictors of Non-Stenting Strategy for Acute Coronary Syndrome Caused by Plaque Erosion: 4-Year Outcomes of the EROSION Study

He L, Qin Y, Xu Y, Hu S, Wang Y, Zeng M, Feng X, Liu Q, Syed I, Demuyakor A, Zhao C, Chen X, Li Z, Meng W, Xu M, Liu H, Ma L, Dai J, Xing L, Yu H, Hou J, Jia H, Mintz G, Yu B

November 10, 2020 | 10.4244/EIJ-D-20-00299

Coronary interventions

Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST elevation myocardial infarction: results from the randomised RE-DUAL PCI trial

Zeymer U, Leiva O, Hohnloser SH, Steg P, Oldgren J, Nickenig G, Gabor Kiss R, Ongen Z, Navarro Estrada J, Oude Ophuis T, Lip GY, Nordaby M, Miede C, ten Berg J, Bhatt D, Cannon C

November 10, 2020 | 10.4244/EIJ-D-20-00799

Coronary interventions

In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19

Rodriguez-Leor O, Cid-Alvarez B, Pérez de Prado A, Rossello X, Ojeda S, Serrador A, López-Palop R, Martin-Moreiras J, Rumoroso J, Cequier A, Ibáñez B, Cruz-Gonzalez I, Romaguera R, Moreno R

November 10, 2020 | 10.4244/EIJ-D-20-00935

Coronary interventions

The EURO SHOCK Trial: Design, Aims and Objectives Randomised comparison of Extra Corporeal Membrane Oxygenation (ECMO) delivered after acute-PCI plus standard of care versus standard of care alone after acute PCI, in patients presenting with Acute Coronary syndrome and Cardiogenic Shock.

Banning A, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, Guagliumi G, Haine S, Kastrati A, Massberg S, Orban M, Myrmel T, Vuylsteke A, Alfonso F, Van de Werf F, Verheugt F, Flather M, Sabaté M, Vrints C, Gershlick A, Gracey J, Ferguson M, Mueller J, Bousfield P, Yusuff H, Taylor C

October 27, 2020 | 10.4244/EIJ-D-20-01076

Coronary interventions

Culprit lesion location and outcomes in patients with multi-vessel disease and infarct-related cardiogenic shock. A core laboratory analysis of the CULPRIT-SHOCK trial

Hauguel-Moreau M, Barthelemy O, Farhan s, Huber K, Rouanet S, Zeitouni M, Guedeney P, Hage G, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G

September 8, 2020 | 10.4244/EIJ-D-20-00561

Coronary interventions

Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis

Dancy L, Abu-Own H, Byrne J, Pareek N

July 28, 2020 | 10.4244/EIJ-D-20-00636

Coronary interventions

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs. Ticagrelor in Stabilized Patients with Acute Myocardial Infarction after Percutan eous Coronary Intervention: rationale and design of the TALOS-AMI trial

Park M, Kim C, Kim M, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong M, Seung K, Ahn Y, Chang K

July 28, 2020 | 10.4244/EIJ-D-20-00187

Coronary interventions

Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial

Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P, Mantas I, Foukarakis E, Kanonidis I, Ziakas A, Tzikas S, Papaioannou G, Draganigos A, Ikonomou G, Damelou A, Samiotis I, Kampouridis N, Tsounos I, Chlouverakis G, Kochiadakis G, Petousis S, Skalidis E, Zacharis E, Parthenakis F, Nikolaou A

July 21, 2020 | 10.4244/EIJ-D-20-00268

1
2
3
…
8

Valvular disease